Skip to main content
RT @EBRheum: #ACR19 - AM session re:classification vs diagnostic criteria, referencing 2016 Sjogrens Guidelines

1. Designed for rsrch
2. M…

Mike Putman EBRheum

7 months 2 weeks ago
#ACR19 - AM session re:classification vs diagnostic criteria, referencing 2016 Sjogrens Guidelines 1. Designed for rsrch 2. May miss important cases (lower sensitivity) 3. Not intended for diagnosis Remember this when using them in practice! @RheumNow https://t.co/KHWyVYjOjM https://t.co/xyOpkh9mSC
RT @Janetbirdope: Killed zoster vaccine was safe with no flare of RA and PsA We need to know if response was good. #ACR19 @RheumNow abst2…

Janet Pope Janetbirdope

7 months 2 weeks ago

Killed zoster vaccine was safe with no flare of RA and PsA We need to know if response was good. #ACR19 @RheumNow abst2093 https://t.co/xp2Ju5wZWK

RT @Janetbirdope: Do you combine bDMARD with apremilast? #ACR #ACR19 @RheumNow abstract 1481

Janet Pope Janetbirdope

7 months 2 weeks ago
Do you combine bDMARD with apremilast? #ACR #ACR19 @RheumNow abstract 1481
RT @CCalabreseDO: retrospective study using Medicare claims data demonstrates lower risk of infection-related hospitalization with abatacep…

Cassandra Calabrese CCalabreseDO

7 months 2 weeks ago
retrospective study using Medicare claims data demonstrates lower risk of infection-related hospitalization with abatacept compared to other biologics, in RA patients previously exposed to TNFi. Abstr#1801 #ACR19 @RheumNow
RT @CCalabreseDO: ICIR data showing Checkpoint inhibitor-related Sjogrens is different! More men, older patients, seronegative. Dry mouth >…

Cassandra Calabrese CCalabreseDO

7 months 2 weeks ago
ICIR data showing Checkpoint inhibitor-related Sjogrens is different! More men, older patients, seronegative. Dry mouth >>dry eyes. Abstr#1905 #ACR19 @RheumNow @LCalabreseDO #cleclinicrheum
RT @synovialjoints: PREVENT trial of Secukinumabnr-axSpA. SEC 150 mg loading and no loading dose provided significant improvement in signs…

Dr. Antoni Chan synovialjoints

7 months 2 weeks ago

PREVENT trial of Secukinumabnr-axSpA. SEC 150 mg loading and no loading dose provided significant improvement in signs and symptoms of nr-axSpA through Wk 16. The safety profile of SEC was consistent with the established safety profile across indications #L2 #ACR19 @RheumNow

RT @synovialjoints: The cytokine storm syndromes including MAS, HLH, autoinflammatory disease. Cron R #ACR19 #acrbest @RheumNow https://t.c…

Dr. Antoni Chan synovialjoints

7 months 2 weeks ago
The cytokine storm syndromes including MAS, HLH, autoinflammatory disease. Cron R #ACR19 #acrbest @RheumNow https://t.co/oy2QPHk8jh
RT @DrKanikaMonga: Immune-mediated causes of uveitis
• Behcet’s disease
• Cogan’s syndrome
• IBD
• TINU
• JIA
• Multiple sclerosis

Kanika Monga, MD DrKanikaMonga

7 months 2 weeks ago
Immune-mediated causes of uveitis • Behcet’s disease • Cogan’s syndrome • IBD • TINU • JIA • Multiple sclerosis • Psoriatic arthritis/ AS/ Reactive Arthritis • Relapsing polychondritis • Sarcoidosis • SLE • Vasculitis • Vogt-Koyanagi-Harada Syndrome #ACR19 @RheumNow
RT @DrKanikaMonga: MTX v. Mycophenolate – FAST uveitis trial
– 265 adults with non-infectious uveitis
– Oral MTX 25 mg v. MMF 3 grams daily…

Kanika Monga, MD DrKanikaMonga

7 months 2 weeks ago
MTX v. Mycophenolate – FAST uveitis trial – 265 adults with non-infectious uveitis – Oral MTX 25 mg v. MMF 3 grams daily – MTX non-inferior to mycophenolate Ophthalmology, 2018. 125(2):193. JAMA, 2019. 322(10):936. #ACR19 @RheumNow
Romosozumab and Patients with Chronic Kidney Disease: Dr. Arthur Lau

Dr. Lau discusses abstract #2730 presented at the 2019 ACR/ARP annual meeting in Atlanta. 

New Treatments for Axial Spondyloarthritis: Dr. Antoni Chan

Dr. Chan discusses several studies on spondyloarthritis presented at the 2019 ACR/ARP annual meeting in Atlanta. 

Ixekizimab Withdrawal in PSA: Dr. Eric Ruderman

Dr. Ruderman highlights abstract #1532 at the 2019 ACR/ARP annual meeting in Atlanta.

Capitol washington congress
2021 E/M Coding Update
Rachel Tate, DO
As a rheumatologist, I pride myself on being an advocate for my patients, but I'm not always an advocate for my profession or myself. Should rheumatologists be involved in policy? Should we be political? 
RT @DrKanikaMonga: Abstract #0626Are there really differences between non-radiographic and radiographic axial spondyloarthritis? Data from…

Kanika Monga, MD DrKanikaMonga

7 months 2 weeks ago

Abstract #0626 Are there really differences between non-radiographic and radiographic axial spondyloarthritis? Data from the Spanish Atlas #ACR19 @RheumNow https://t.co/hg3U2QjpFp

RT @KDAO2011: More than half of rheums who tweet and answer polls at #acr19 don’t look at synovial fluid anymore (maybe even more don’t in…

k dao KDAO2011

7 months 2 weeks ago
More than half of rheums who tweet and answer polls at #acr19 don’t look at synovial fluid anymore (maybe even more don’t in the real world) due to time constraints— your thoughts? @Rheumnow https://t.co/78d6MwbsXB
RT @DrKanikaMonga: Poor prognostic factors for MDA-5 ILD:
- Ferritin > 1000 ng/mL prior Rx
- GCO or consolidations in all lung fields
- Wor…

Kanika Monga, MD DrKanikaMonga

7 months 2 weeks ago
Poor prognostic factors for MDA-5 ILD: - Ferritin > 1000 ng/mL prior Rx - GCO or consolidations in all lung fields - Worsening of lung consolidations during Rx #ACR19 @RheumNow
RT @DrKanikaMonga: Myositis -- Ask for muscle biopsy when:
- high clinical suspicion w/ negative myositis specific antibodies
- high clinic…

Kanika Monga, MD DrKanikaMonga

7 months 2 weeks ago
Myositis -- Ask for muscle biopsy when: - high clinical suspicion w/ negative myositis specific antibodies - high clinical suspicion of inherited muscle disease - isolated elevated CPK - recalcitrant to treatment - atypical presentation #ACR19 @RheumNow
Social Media Tips: Dr. Paul Sufka

Dr. Sufka reviews tips offered during a session on social media professionalism at the 2019 ACR/ARP annual meeting in Atlanta. 

TULIP Trials in Lupus: Dr. Mike Putman

Dr. Putman discusses abstracts # L17 and 1763 presented at the 2019 ACR/ARP annual meeting in Atlanta. 

Comparison of Ixekizumab and Adalimumab in PsA: Dr. Olga Petryna

Dr. Petryna discusses abstract #L20 presented at the 2019 ACR/ARP annual meeting in Atlanta. 

Overview of Several Gout Studies: Dr. Philip Robinson

Dr. Robinson highlights a number of gout-related abstracts, including #1236, #1217, #1218, #1235, at the ACR/ARP annual meeting in Atlanta. 

Subcutaneous Biosimilar: Dr. Jonathan Kay

Dr. Kay highlights abstract #548 presented at the 2019 ACR/ARP annual meeting in Atlanta. 

RT @Janetbirdope: Sjogrens RCT of Tocilizumab showed no benefit. Wonder re outcomes and pt selection. Maybe pick early pts with high inflam…

Janet Pope Janetbirdope

7 months 2 weeks ago
Sjogrens RCT of Tocilizumab showed no benefit. Wonder re outcomes and pt selection. Maybe pick early pts with high inflammatory markers or other organ involvement #ACR @RheumNow #Sjogrens abstr1904
RT @Janetbirdope: Tofacitinib works in Polyarticular JIA. Maybe new hope for kids with JIA and benefits of oral medication #ACR #ACR19 #JIA…

Janet Pope Janetbirdope

7 months 2 weeks ago

Tofacitinib works in Polyarticular JIA. Maybe new hope for kids with JIA and benefits of oral medication #ACR #ACR19 #JIA @RheumNow L23.

RT @DrKanikaMonga: Myositis-specific autoantibodies (MSA): an important tool to support the diagnosis of myositis

#ACR19 @RheumNow https:/…

Kanika Monga, MD DrKanikaMonga

7 months 2 weeks ago
Myositis-specific autoantibodies (MSA): an important tool to support the diagnosis of myositis #ACR19 @RheumNow https://t.co/vgW2wxkemr
RT @Janetbirdope: Certrolizumab pegol decreases uveitis in open label study of SpA with past uveitis and HLAB27 group enriched for recurren…

Janet Pope Janetbirdope

7 months 2 weeks ago
Certrolizumab pegol decreases uveitis in open label study of SpA with past uveitis and HLAB27 group enriched for recurrence. Pre and post Rx rates of uveitis were compared. 80% reduction of uveitis but uncontrolled and unblinded. #ACR #ACR19 @RheumNow
RT @Janetbirdope: 1/3 of pts using apremilast with PsA/SpA from Corrona data base are using it in combination with bDMARDs. Not sure how th…

Janet Pope Janetbirdope

7 months 2 weeks ago

1/3 of pts using apremilast with PsA/SpA from Corrona data base are using it in combination with bDMARDs. Not sure how they get reimbursement #ACR #ACR19 #psoriaticarthritis @RheumNow abstract 1481

RT @DrKanikaMonga: 2020 Gout Clinical Practice Guideline
❕Regardless of disease activity, conditionally recommend
- limit alcohol intake
-…

Kanika Monga, MD DrKanikaMonga

7 months 2 weeks ago
2020 Gout Clinical Practice Guideline ❕Regardless of disease activity, conditionally recommend - limit alcohol intake - limit purine intake - limit high-fructose corn syrup - if overweight/obese, recommend weight loss - against adding vitamin C supplementation #ACR19 @RheumNow
RT @DrKanikaMonga: @RheumNow 2020 Gout Clinical Practice Guideline‼️ For allopurinol and febuxostat, strongly recommend starting at low do…

Kanika Monga, MD DrKanikaMonga

7 months 2 weeks ago

@RheumNow 2020 Gout Clinical Practice Guideline ‼️ For allopurinol and febuxostat, strongly recommend starting at low dose with subsequent dose titration to target over starting at higher dose ( ≤ 100 mg/d for allopurinol, ≤ 40 mg/d for febuxostat) #ACR19 @RheumNow

RT @Janetbirdope: Gout guidelines make total clinical sense. Congrats ACR and Goit me@bers for a monumental job #ACR @RheumNow https://t.co…

Janet Pope Janetbirdope

7 months 2 weeks ago

Gout guidelines make total clinical sense. Congrats ACR and Goit me@bers for a monumental job #ACR @RheumNow https://t.co/A0iwU0WPlZ

RT @EBRheum: All the NEW Clinical Practice Guidelines for GOUT!

1. Allopurinol is 1st line
2. Start ULT during flare!
3. No tx for asympt…

Mike Putman EBRheum

7 months 2 weeks ago
All the NEW Clinical Practice Guidelines for GOUT! 1. Allopurinol is 1st line 2. Start ULT during flare! 3. No tx for asymptomatic hyperuricemia Seems pretty reasonable - surprised no rec for MTX w/pegloticase #ACR19 @RheumNow Thank you to @philipcrobinson for posting slides! https://t.co/riwHGYNZ8T
RT @DrKanikaMonga: 2020 Gout Clinical Practice Guideline
42 recommendations (16 strong)
- 27 ULT management (13 strong)
- 5 Gout Flares (3…

Kanika Monga, MD DrKanikaMonga

7 months 2 weeks ago
2020 Gout Clinical Practice Guideline 42 recommendations (16 strong) - 27 ULT management (13 strong) - 5 Gout Flares (3 strong) - 5 Lifestyle recommendations - 4 Management of other medications - 1 Asymptomatic Hyperuricemia #ACR19 @RheumNow
RT @hausmannMD: Pericarditis is an inflammatory condition that causes chest pain, pericardial friction rub, pericardial effusion.

#ACR19 @…

Jonathan Hausmann MD hausmannMD

7 months 2 weeks ago
Pericarditis is an inflammatory condition that causes chest pain, pericardial friction rub, pericardial effusion. #ACR19 @RheumNow
RT @uptoTate: MAXIMISE results in axial manifestations of PsA. SEC met primary phase 3b ASAS 20 endpoint after inadequate NSAID response. h…

Dr. Rachel Tate uptoTate

7 months 3 weeks ago

MAXIMISE results in axial manifestations of PsA. SEC met primary phase 3b ASAS 20 endpoint after inadequate NSAID response. https://t.co/e1j03KOo1K #ACR19 @RheumNow abs#2880 https://t.co/UtSDJGAW2G

×